---
category: news
title: "BioXcel Therapeutics Presents Positive Data from Phase 2"
excerpt: "BXCL701 is currently being developed as therapy for metastatic castration-resistant prostate ... Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno ..."
publishedDateTime: 2022-02-14T23:20:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-presents-positive-data-from-phase-2-/2022/02/14/9544920.htm"
webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-presents-positive-data-from-phase-2-/2022/02/14/9544920.htm"
type: article
quality: 4
heat: 4
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "XEUkI+H8eB98r8cYIIT40xmhS9yFtiRXE9ASUhI7lRxtGlS/RDFIYCRmcjdao7HsmCtgRfgw/qhdSI3h4fX4PtdyiadVjlxYvBD7HHBgz0sfqf8704KnJxulcXlYoED4C3DXpr8BUbUIJ0rqr+i0UJ2lEqjIRXCCjSg4qAO7oU3HEVBnxrxknl/L3h/kbmku63CGiSQm9vxENCFVcGxXSnkWsDB9p97jQPPci7nIGCs4dIA/ND1EU8AvVVi3lNGwkYpOp8xRKX/J8gUffAb0bOi1UUm1JhbjK3e50oKDf/Lto3dQqsc8Wq8rSqWNMcS+txcPzOFJSSXth1Q1Wf88fm5UPyvrFOpLQfHLSdfnTaU=;31Dbkanf5qwNzm4Ba/L+og=="
---

